Drug Shortage Report for OMNIPAQUE 350
| Report ID | 255099 |
| Drug Identification Number | 02172755 |
| Brand name | OMNIPAQUE 350 |
| Common or Proper name | iohexol injection USP |
| Company Name | GE HEALTHCARE CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | IOHEXOL |
| Strength(s) | 755MG |
| Dosage form(s) | SOLUTION |
| Route of administration | ORAL INTRAVASCULAR INTRAVASCULAR |
| Packaging size | 50 mL |
| ATC code | V08AB |
| ATC description | X-RAY CONTRAST MEDIA, IODINATED |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2025-04-15 |
| Estimated end date | 2025-04-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-04-16 |
| Company comments | Reason for shortage - manufacturing delay |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1919 MINNESOTA COURT MISSISSAUGA, ONTARIO CANADA L5N 0C9 |
| Company contact information | 800-387-7146 canadainfo@gehealthcare.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2025-04-16 | English | Compare |
| v2 | 2025-04-15 | French | Compare |
| v1 | 2025-04-15 | English | Compare |
Showing 1 to 3 of 3